|
|
Other Issues: Journal List
|
previous
|
next
|
latest
|
archive
Meeting Report It's all in the details: methods in breast development and cancer Mohamed Bentires-Alj, Robert B Clarke, Jos Jonkers, Matthew Smalley, and Torsten Stein Breast Cancer Res. 2009; 11(4): 305. Published online 2009 August 14. doi: 10.1186/bcr2346.PMCID: PMC2750118 | Free in PMC on 2010/02/14 | Viewpoint Transforming growth factor-beta and mutant p53 conspire to induce metastasis by antagonizing p63: a (ternary) complex affair Jean-Christophe Marine and Geert Berx Breast Cancer Res. 2009; 11(4): 304. Published online 2009 July 27. doi: 10.1186/bcr2337.PMCID: PMC2750109 | Free in PMC on 2010/01/27 | Research Articles Dynamics of different-sized solid-state nanocrystals as tracers for a drug-delivery system in the interstitium of a human tumor xenograft Masaaki Kawai, Hideo Higuchi, Motohiro Takeda, Yoshio Kobayashi, and Noriaki Ohuchi Breast Cancer Res. 2009; 11(4): R43. Published online 2009 July 3. doi: 10.1186/bcr2330.PMCID: PMC2750102 Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study Mette Kalager, Tor Haldorsen, Michael Bretthauer, Geir Hoff, Steinar O Thoresen, and Hans-Olov Adami Breast Cancer Res. 2009; 11(4): R44. Published online 2009 July 6. doi: 10.1186/bcr2331.PMCID: PMC2750103 Increased levels of active c-Src distinguish invasive from in situ lobular lesions Donghui Zou, Han-Seung Yoon, Ahmad Anjomshoaa, David Perez, Ryuji Fukuzawa, Parry Guilford, and Bostjan Humar Breast Cancer Res. 2009; 11(4): R45. Published online 2009 July 7. doi: 10.1186/bcr2332.PMCID: PMC2750104 Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients Bahriye Aktas, Mitra Tewes, Tanja Fehm, Siegfried Hauch, Rainer Kimmig, and Sabine Kasimir-Bauer Breast Cancer Res. 2009; 11(4): R46. Published online 2009 July 9. doi: 10.1186/bcr2333.PMCID: PMC2750105 Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes Olafur Andri Stefansson, Jon Gunnlaugur Jonasson, Oskar Thor Johannsson, Kristrun Olafsdottir, Margret Steinarsdottir, Sigridur Valgeirsdottir, and Jorunn Erla Eyfjord Breast Cancer Res. 2009; 11(4): R47. Published online 2009 July 9. doi: 10.1186/bcr2334.PMCID: PMC2750106 Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years Naoko Honma, Kaiyo Takubo, Motoji Sawabe, Tomio Arai, Futoshi Akiyama, Goi Sakamoto, Toshiaki Utsumi, Noriko Yoshimura, and Nobuhiro Harada Breast Cancer Res. 2009; 11(4): R48. Published online 2009 July 10. doi: 10.1186/bcr2335.PMCID: PMC2750107 Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case-control study Meira Epplein, Yurii B Shvetsov, Lynne R Wilkens, Adrian A Franke, Robert V Cooney, Loïc Le Marchand, Brian E Henderson, Laurence N Kolonel, and Marc T Goodman Breast Cancer Res. 2009; 11(4): R49. Published online 2009 July 20. doi: 10.1186/bcr2338.PMCID: PMC2750110 Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer Andrea Sassen, Simone Diermeier-Daucher, Manuela Sieben, Olaf Ortmann, Ferdinand Hofstaedter, Stephan Schwarz, and Gero Brockhoff Breast Cancer Res. 2009; 11(4): R50. Published online 2009 July 22. doi: 10.1186/bcr2339.PMCID: PMC2750111 Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women Carolyn J Crandall, Mary E Sehl, Sybil L Crawford, Ellen B Gold, Laurel A Habel, Lesley M Butler, MaryFran R Sowers, Gail A Greendale, and Janet S Sinsheimer Breast Cancer Res. 2009; 11(4): R51. Published online 2009 July 27. doi: 10.1186/bcr2340.PMCID: PMC2750112 A novel role for signal transducer and activator of transcription 5b (STAT5b) in β1-integrin-mediated human breast cancer cell migration Teresa M Bernaciak, Jessica Zareno, J Thomas Parsons, and Corinne M Silva Breast Cancer Res. 2009; 11(4): R52. Published online 2009 July 24. doi: 10.1186/bcr2341.PMCID: PMC2750113 Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer Miguel A Trujillo, Michael J Oneal, Julia Davydova, Elizabeth Bergert, Masato Yamamoto, and John C Morris, III Breast Cancer Res. 2009; 11(4): R53. Published online 2009 July 27. doi: 10.1186/bcr2342.PMCID: PMC2750114 Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment Marc A Bollet, Alexia Savignoni, Leanne De Koning, Carine Tran-Perennou, Catherine Barbaroux, Armelle Degeorges, Brigitte Sigal-Zafrani, Geneviève Almouzni, Paul Cottu, Rémy Salmon, Nicolas Servant, Alain Fourquet, and Patricia de Cremoux Breast Cancer Res. 2009; 11(4): R54. Published online 2009 July 28. doi: 10.1186/bcr2343.PMCID: PMC2750115 An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer Andrea H Bild, Joel S Parker, Adam M Gustafson, Chaitanya R Acharya, Katherine A Hoadley, Carey Anders, P Kelly Marcom, Lisa A Carey, Anil Potti, Joseph R Nevins, and Charles M Perou Breast Cancer Res. 2009; 11(4): R55. Published online 2009 July 28. doi: 10.1186/bcr2344.PMCID: PMC2750116 Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis Lopamudra Das Roy, Latha B Pathangey, Teresa L Tinder, Jorge L Schettini, Helen E Gruber, and Pinku Mukherjee Breast Cancer Res. 2009; 11(4): R56. Published online 2009 July 30. doi: 10.1186/bcr2345.PMCID: PMC2750117 The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition Jianxun Han, Ivy Ma, Michael J Hendzel, and Joan Allalunis-Turner Breast Cancer Res. 2009; 11(4): R57. Published online 2009 August 6. doi: 10.1186/bcr2347.PMCID: PMC2750119 MicroRNA expression profiling of male breast cancer Matteo Fassan, Raffaele Baffa, Juan P Palazzo, Joshua Lloyd, Marco Crosariol, Chang-Gong Liu, Stefano Volinia, Hannes Alder, Massimo Rugge, Carlo M Croce, and Anne Rosenberg Breast Cancer Res. 2009; 11(4): R58. Published online 2009 August 10. doi: 10.1186/bcr2348.PMCID: PMC2750120 Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells Tanja Fehm, Oliver Hoffmann, Bahriye Aktas, Sven Becker, Erich F Solomayer, Diethelm Wallwiener, Rainer Kimmig, and Sabine Kasimir-Bauer Breast Cancer Res. 2009; 11(4): R59. Published online 2009 August 10. doi: 10.1186/bcr2349.PMCID: PMC2750121 Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer Mark R Pickard, Andrew R Green, Ian O Ellis, Carlos Caldas, Vanessa L Hedge, Mirna Mourtada-Maarabouni, and Gwyn T Williams Breast Cancer Res. 2009; 11(4): R60. Published online 2009 August 11. doi: 10.1186/bcr2350.PMCID: PMC2750122 Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression Brandy M Heckman-Stoddard, Tracy Vargo-Gogola, Peter R McHenry, Vivian Jiang, Matthew P Herrick, Susan G Hilsenbeck, Jeffrey Settleman, and Jeffrey M Rosen Breast Cancer Res. 2009; 11(4): R61. Published online 2009 August 24. doi: 10.1186/bcr2352.PMCID: PMC2750123 Resident macrophages influence stem cell activity in the mammary gland David E Gyorki, Marie-Liesse Asselin-Labat, Nico van Rooijen, Geoffrey J Lindeman, and Jane E Visvader Breast Cancer Res. 2009; 11(4): R62. Published online 2009 August 26. doi: 10.1186/bcr2353.PMCID: PMC2750124 BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A Julian Puppe, Rinske Drost, Xiaoling Liu, Simon A Joosse, Bastiaan Evers, Paulien Cornelissen-Steijger, Petra Nederlof, Qiang Yu, Jos Jonkers, Maarten van Lohuizen, and Alexandra M Pietersen Breast Cancer Res. 2009; 11(4): R63. Published online 2009 August 26. doi: 10.1186/bcr2354.PMCID: PMC2750125 Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort Marjorie L McCullough, Victoria L Stevens, Roshni Patel, Eric J Jacobs, Elizabeth B Bain, Ronald L Horst, Susan M Gapstur, Michael J Thun, and Eugenia E Calle Breast Cancer Res. 2009; 11(4): R64. Published online 2009 August 28. doi: 10.1186/bcr2356.PMCID: PMC2750126 Reviews Recent advances in systemic therapy: Advances in systemic therapy for HER2-positive metastatic breast cancer Phuong Khanh H Morrow, Francisco Zambrana, and Francisco J Esteva Breast Cancer Res. 2009; 11(4): 207. Published online 2009 July 15. doi: 10.1186/bcr2324.PMCID: PMC2750101 | Free in PMC on 2010/01/15 | Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer David W Miles Breast Cancer Res. 2009; 11(4): 208. Published online 2009 August 28. doi: 10.1186/bcr2237.PMCID: PMC2750099 | Free in PMC on 2010/02/28 | Editorials Is there more to Wnt signalling in breast cancer than stabilisation of β-catenin? Giovanna M Collu, Olivier Meurette, and Keith Brennan Breast Cancer Res. 2009; 11(4): 105. Published online 2009 July 30. doi: 10.1186/bcr2336.PMCID: PMC2750108 Recent advances in systemic therapy for breast cancer: new technologies for a new era Paul Ellis Breast Cancer Res. 2009; 11(4): 107. Published online 2009 August 28. doi: 10.1186/bcr2254.PMCID: PMC2750100
Other Issues: Journal List
|
previous
|
next
|
latest
|
archive
|